Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17177
Country/Region: Democratic Republic of the Congo
Year: 2016
Main Partner: SANRU
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $1,000,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $100,508
Care: TB/HIV (HVTB) $100,000
Care: Pediatric Care and Support (PDCS) $75,000
Laboratory Infrastructure (HLAB) $30,500
Health Systems Strengthening (OHSS) $69,942
Biomedical Prevention: Injection Safety (HMIN) $3,000
Testing: HIV Testing and Counseling (HVCT) $75,000
Sexual Prevention: Other Sexual Prevention (HVOP) $45,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $175,000
Treatment: Adult Treatment (HTXS) $251,050
Treatment: Pediatric Treatment (PDTX) $75,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,253
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,503
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 16,795
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 4,508
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 25,059
HTS_TST Service Delivery Point (Facility): Index testing 2017 79
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,827
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 688
HTS_TST Service Delivery Point (Facility): Other PITC 2017 688
HTS_TST Service Delivery Point (Facility): Outpatient 2017 4,265
HTS_TST Service Delivery Point (Facility): Pediatric 2017 3,372
HTS_TST Service Delivery Point (Facility): PMTCT 2017 13,154
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 908
HTS_TST Service Delivery Point (Facility): VCT 2017 78
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,756
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 21,303
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 25,059
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 76
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 51
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 325
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 161
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 18
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 24
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 30
PMTCT_ART Already on ART at beginning of current pregnancy 2017 25
PMTCT_ART New on ART 2017 196
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 13,154
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 96
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 117
PMTCT_EID Sum of Infant Age disaggregates 2017 213
PMTCT_STAT By: Known positives at entry 2017 27
PMTCT_STAT By: Number of new positives identified 2017 192
PMTCT_STAT Number of new ANC and L&D clients 2017 13,592
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 13,154
PMTCT_STAT Sum of Positives Status disaggregates 2017 219
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 66
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 96
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 182
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 165
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 326
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 14
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 273
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 41
TB_SCREENDX Screen Result: Screened Positive for TB 2017 362
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 709
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 937
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 75
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 89
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 1,813
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 27
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 342
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 42
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 453
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 863
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 908
TX_CURR Aggregated Age/Sex: <15 Female 2017 195
TX_CURR Aggregated Age/Sex: <15 Male 2017 131
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,475
TX_CURR Aggregated Age/Sex: 15+ Male 2017 467
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,269
TX_CURR Sum of Aggregated Age/Sex <15 2017 326
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,942
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,268
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 68
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 41
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 372
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 99
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 572
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 580
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,589
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,110
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 69
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 42
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 723
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 277
TX_PVLS Numerator: Indication: Routine 2017 1,055
TX_PVLS Numerator: Indication: Targeted 2017 55
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 95
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 68
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,034
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 391
TX_PVLS_den Denominator: Indication: Routine 2017 1,509
TX_PVLS_den Denominator: Indication: Targeted 2017 80
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 273
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 115
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 421
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 524
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 26
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 343
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 138
Cross Cutting Budget Categories and Known Amounts Total: $20,000
Human Resources for Health $20,000